NEWTOWN, PA — Onconova Therapeutics, Inc. (NASDAQ: ONTX), a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for patients with cancer, announced that its President and CEO, Steven Fruchtman, M.D., will be presenting at the upcoming NobleCon19. This event is Noble Capital Markets’ Nineteenth Annual Emerging Growth Equity Conference.
The conference, known for bringing together companies and investors in the small and micro-cap sectors, will take place from December 3-5, 2023, at the Executive Education Complex of Florida Atlantic University in Boca Raton, FL.
Dr. Fruchtman’s presentation is scheduled for Monday, December 4, 2023, at 10:30 AM ET, followed by a breakout session. The Onconova Management Team will also be available for one-on-one meetings during the conference. Interested attendees should reach out to their Noble Capital Markets representative to request a meeting.
This presentation represents yet another opportunity for Onconova Therapeutics to highlight its recent advancements and future prospects to an audience of potential investors and industry professionals. The company’s dedication to developing innovative treatments for cancer has positioned it as a notable player in the biopharmaceutical space.
A webcast of Dr. Fruchtman’s presentation will be available the following day in the “Corporate Events and Presentations” section of the Onconova website. It will also be part of a complete catalog of presentations available at the Noble Capital Markets’ Conference website and on Channelchek. The webcast will be archived on these platforms for 90 days following the event, offering those unable to attend the live presentation an opportunity to hear Dr. Fruchtman’s insights.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.